Skip to main content
SEER
NASDAQ Life Sciences

Seer Reports 34% Q1 Revenue Drop to $2.8M, Reaffirms Full-Year Guidance

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.7
Mkt Cap
$99.865M
52W Low
$1.65
52W High
$2.41
52W Position info
3.0% above low
Off High info
29% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

SEER is trading near its 52-week low of $1.65 (3.0% above the low).

Summary

Seer reported a significant 34% year-over-year decline in first-quarter 2026 revenue, reaching $2.8 million, primarily due to a depressed academic funding environment and competitive activity. Despite the revenue drop, the company reaffirmed its full-year 2026 revenue outlook of $16 million to $18 million, implying a substantial recovery in the remaining quarters. Positively, Seer also reported an improved net loss of $16.8 million, down from $19.9 million in the prior year, driven by a 20% reduction in operating expenses. The company ended the quarter with a strong cash position of approximately $220 million and highlighted operational achievements including a new collaboration and successful IP defense, following a recent CCO appointment and patent lawsuit. Traders will weigh the concerning revenue miss against management's confidence in the full-year outlook and the company's cost control efforts and strong cash balance.

At the time of this announcement, SEER was trading at $1.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $99.9M. The 52-week trading range was $1.65 to $2.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Nov 10, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.47 info
Change: -$0.080 (-5%) info
Market Cap: $81.49M info
SEER
Nov 10, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.47 info
Change: -$0.070 (-5%) info
Market Cap: $81.49M info
SEER
Nov 02, 2026, 2:08 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.47 info
Change: -$0.265 (-15%) info
Market Cap: $81.49M info
SEER
Nov 02, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $1.47 info
Change: -$0.170 (-10%) info
Market Cap: $81.49M info
SEER
Oct 29, 2026, 4:30 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.47 info
Change: -$0.2823 (-16%) info
Market Cap: $81.49M info